Novoic is a brand that specializes in AI-enabled software for detecting subtle cognitive impairment and Alzheimer's neuropathology based on how people speak. Their innovative algorithms are revolutionizing early Alzheimer's detection, providing faster and more accurate results for over 50 institutions. Novoic's speech-based testing offers scalable access to early detection, addressing the current lack of accessibility in underserved communities.

Their automated assessment is a low-burden, high usability experience that can be done on any smart device. Novoic maximizes data integrity through engineering innovations, ensuring accurate and reliable results. With better algorithms and advanced AI models, Novoic's testing accurately detects mild cognitive impairment and predicts amyloid PET positivity.

Their next-generation algorithms have undergone gold standard validation through clinical trials and diverse datasets. Used by leading organizations, Novoic's software provides AI-assisted triage, intuitive UI, and powerful enterprise features for digital screening and monitoring at scale. With a strong focus on privacy, security, and quality, Novoic ensures your data is protected throughout their ecosystem.

Join 50+ top institutions and experience the superpowers that Novoic's tools can provide in revolutionizing patient detection and management